Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Coronavirus Spike Glycoprotein (CoV S) peptide (Cy5)

CoV S Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2) Host: Synthetic InhA
Catalog No. ABIN6952489
  • Target See all Coronavirus Spike Glycoprotein (CoV S) products
    Coronavirus Spike Glycoprotein (CoV S)
    Origin
    Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
    Source
    • 1
    Synthetic
    Purification tag / Conjugate
    This Coronavirus Spike Glycoprotein peptide is labelled with Cy5.
    Application
    Inhibition Assay (InhA)
    Sequence
    Cy5-SLDQINVTFL DLEYEMKKLE EAIKKLEESY IDLKEL
    Characteristics
    EK1 / Pan-HCoV S Inhibitor - Cy5 Labeled
    Purity
    ≥ 90 %
    Components
    Each vial contains 1 nmol of NET labeled peptide.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Powder
    Storage
    4 °C
    Storage Comment
    Store in dry form in a dark place with temperature 0-5°C.
  • Xia, Zhu, Liu, Lan, Xu, Wu, Ying, Liu, Shi, Jiang, Lu: "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein." in: Cellular & molecular immunology, (2020) (PubMed).

    Lu: "Drug treatment options for the 2019-new coronavirus (2019-nCoV)." in: Bioscience trends, Vol. 14, Issue 1, pp. 69-71, (2020) (PubMed).

    Xia, Yan, Xu, Agrawal, Algaissi, Tseng, Wang, Du, Tan, Wilson, Jiang, Yang, Lu: "A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike." in: Science advances, Vol. 5, Issue 4, pp. eaav4580, (2019) (PubMed).

  • Target
    Coronavirus Spike Glycoprotein (CoV S)
    Synonyms
    E2 Peptide, E2 glycoprotein precursor Peptide, S Peptide
    Target Type
    Viral Protein
    Molecular Weight
    4332
You are here:
Support